Table 3.

Multivariate survival analysis of OS and DFS in patients with endometrial endometrioid adenovarcinoma

Variables	OS			DFS
	Exp(B)	95% CI	P a	Exp(B)	95% CI	P a
RRBP1	9.456	1.202–74.352	P = 0.033	12.059	1.592–91.327	P = 0.016
Lymph node metastasis	20.813	4.895–88.502	P <0.001	8.698	3.121–24.237	P <0.001

FIGO, International Federation of Gynecology and Obstetrics; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; RRBP1, Ribosome-binding protein 1; OS, overall survival; DFS, disease-free survival; ^aCox regression test